Your browser doesn't support javascript.
loading
Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level.
Johnson, Erik C B; Carter, E Kathleen; Dammer, Eric B; Duong, Duc M; Gerasimov, Ekaterina S; Liu, Yue; Liu, Jiaqi; Betarbet, Ranjita; Ping, Lingyan; Yin, Luming; Serrano, Geidy E; Beach, Thomas G; Peng, Junmin; De Jager, Philip L; Haroutunian, Vahram; Zhang, Bin; Gaiteri, Chris; Bennett, David A; Gearing, Marla; Wingo, Thomas S; Wingo, Aliza P; Lah, James J; Levey, Allan I; Seyfried, Nicholas T.
Afiliação
  • Johnson ECB; Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA. erik.c.b.johnson@emory.edu.
  • Carter EK; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA. erik.c.b.johnson@emory.edu.
  • Dammer EB; Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Duong DM; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  • Gerasimov ES; Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Liu Y; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.
  • Liu J; Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Betarbet R; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.
  • Ping L; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  • Yin L; Department of Genetics, Emory University School of Medicine, Atlanta, GA, USA.
  • Serrano GE; Department of Genetics, Emory University School of Medicine, Atlanta, GA, USA.
  • Beach TG; Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Peng J; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  • De Jager PL; Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Haroutunian V; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  • Zhang B; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.
  • Gaiteri C; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.
  • Bennett DA; Banner Sun Health Research Institute, Sun City, AZ, USA.
  • Gearing M; Banner Sun Health Research Institute, Sun City, AZ, USA.
  • Wingo TS; Departments of Structural Biology and Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Wingo AP; Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Lah JJ; Center for Translational & Computational Neuroimmunology, Department of Neurology, Taub Institute, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY, USA.
  • Levey AI; Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Seyfried NT; James J. Peters VA Medical Center MIRECC, Bronx, NY, USA.
Nat Neurosci ; 25(2): 213-225, 2022 02.
Article em En | MEDLINE | ID: mdl-35115731
ABSTRACT
The biological processes that are disrupted in the Alzheimer's disease (AD) brain remain incompletely understood. In this study, we analyzed the proteomes of more than 1,000 brain tissues to reveal new AD-related protein co-expression modules that were highly preserved across cohorts and brain regions. Nearly half of the protein co-expression modules, including modules significantly altered in AD, were not observed in RNA networks from the same cohorts and brain regions, highlighting the proteopathic nature of AD. Two such AD-associated modules unique to the proteomic network included a module related to MAPK signaling and metabolism and a module related to the matrisome. The matrisome module was influenced by the APOE ε4 allele but was not related to the rate of cognitive decline after adjustment for neuropathology. By contrast, the MAPK/metabolism module was strongly associated with the rate of cognitive decline. Disease-associated modules unique to the proteome are sources of promising therapeutic targets and biomarkers for AD.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article